Ftse Mib
36.200,72
0,24%
DAX
21.394,93
-0,11%
S&P 500
6.101,24
-0,29%
NASDAQ
19.954,30
-0,50%
Bitcoin
105.109,61
0,36%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Regno Unito LSE Eli Lilly And Co (0Q1G) Eli Lilly And Co (0Q1G) Notizie

0Q1G

Eli Lilly (0Q1G)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:0Q1G
DataOraFonteTitoloSimboloCompagnia
14/01/202515:33Alliance NewsAlliance NewsEli Lilly shares fall as lowers fourth quarter revenue guidanceLSE:0Q1GEli Lilly And Co
16/12/202408:54Alliance NewsAlliance NewsLSE:0Q1GEli Lilly And Co
26/11/202407:42Alliance NewsAlliance NewsNovo Nordisk diabetes and obesity drugs also protect kidneys — studyLSE:0Q1GEli Lilly And Co
30/10/202413:24Alliance NewsAlliance NewsTOP NEWS: Eli Lilly returns to profit in quarter, downgrades guidanceLSE:0Q1GEli Lilly And Co
09/09/202413:16Alliance NewsAlliance NewsEli Lilly names Lucas Montarce as new chief financial officerLSE:0Q1GEli Lilly And Co
08/08/202413:57Alliance NewsAlliance NewsTOP NEWS: Eli Lilly lifts guidance as Mounjaro and Zepbound sales jumpLSE:0Q1GEli Lilly And Co
08/07/202420:58Alliance NewsAlliance NewsEli Lilly weight loss drug beats Ozempic in head-to-head studyLSE:0Q1GEli Lilly And Co
05/06/202415:00Alliance NewsAlliance NewsTOP NEWS: Alphabet poaches Eli Lilly CFO Anat Ashkenazi for same roleLSE:0Q1GEli Lilly And Co
21/05/202414:14Alliance NewsAlliance News*Eli Lilly: over half of Crohn's disease patients reach remission at 1 year w/ mirikzumabLSE:0Q1GEli Lilly And Co
15/05/202422:07Alliance NewsAlliance NewsEli Lilly reaches settlement with Totality MedispaLSE:0Q1GEli Lilly And Co
30/04/202414:26Alliance NewsAlliance NewsTOP NEWS: Eli Lilly lifts outlook, ramps up production to meet demandLSE:0Q1GEli Lilly And Co
08/03/202416:16Alliance NewsAlliance NewsEli Lilly's Donanemab Alzheimer's drug hit by delaysLSE:0Q1GEli Lilly And Co
06/02/202413:44Alliance NewsAlliance NewsTOP NEWS: Eli Lilly eyes beefier sales amid weight loss drug crazeLSE:0Q1GEli Lilly And Co
26/01/202407:04Alliance NewsAlliance NewsEli Lilly weight loss drug could be supplied to UK 'in weeks'LSE:0Q1GEli Lilly And Co
23/01/202419:48Alliance NewsAlliance NewsIN BRIEF: Eli Lilly hails upbeat trial data for hearing loss therapyLSE:0Q1GEli Lilly And Co
17/11/202315:18Alliance NewsAlliance NewsTOP NEWS: Eli Lilly to invest USD2.5 billion in GermanyLSE:0Q1GEli Lilly And Co
09/11/202307:09Alliance NewsAlliance NewsEli Lilly diabetes drug authorised for weight management, loss in UKLSE:0Q1GEli Lilly And Co
08/11/202321:15Alliance NewsAlliance NewsUS approves highly anticipated Eli Lilly weight loss drugLSE:0Q1GEli Lilly And Co
02/11/202312:42Alliance NewsAlliance NewsTOP NEWS: Eli Lilly cuts yearly outlook on chunky R&D costsLSE:0Q1GEli Lilly And Co
08/08/202313:23Alliance NewsAlliance NewsTOP NEWS: Eli Lilly second quarter profit up, notes pipeline successesLSE:0Q1GEli Lilly And Co
21/06/202320:34Alliance NewsAlliance NewsUS FDA approves Eli Lilly's Jardiance drug for diabetes in childrenLSE:0Q1GEli Lilly And Co
27/04/202314:28Alliance NewsAlliance NewsTOP NEWS: Eli Lilly quarterly revenue down on reduced Covid-19 demandLSE:0Q1GEli Lilly And Co
03/03/202322:20Alliance NewsAlliance NewsIN BRIEF: US FDA approves expanded indication for Eli Lilly's VerzenioLSE:0Q1GEli Lilly And Co
01/03/202314:42Alliance NewsAlliance NewsUS drugmaker Eli Lilly says slashing insulin prices by 70%LSE:0Q1GEli Lilly And Co
02/02/202321:17Alliance NewsAlliance NewsEli Lilly & Co sees quarterly revenue fall amid declining volumesLSE:0Q1GEli Lilly And Co
01/11/202217:24Alliance NewsAlliance NewsEli Lilly lowers full year guidance despite positive earnings figuresLSE:0Q1GEli Lilly And Co
04/08/202213:23Alliance NewsAlliance NewsTOP NEWS: Eli Lilly cuts annual guidance as second quarter disappointsLSE:0Q1GEli Lilly And Co
03/02/202216:17Alliance NewsAlliance NewsEli Lilly sees net income fall but outlook for 2022 remains unchangedLSE:0Q1GEli Lilly And Co
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:0Q1G

La tua Cronologia

BIT
BMPS
Banca Monte Dei Paschi D...
BIT
UCG
Unicredit
BIT
MB
Mediobanca Banca di Cred...
BIT
ISP
Intesa Sanpaolo
BIT
STLAM
Stellantis NV
BIT
ENI
Eni
BIT
ENEL
Enel
BIT
CPR
Davide Campari
BIT
BAMI
Banco BPM
BIT
MONC
Moncler
BIT
SPM
Saipem
BIT
STMMI
ST Microelectronics
BIT
BPE
Bper Banca
BIT
RACE
Ferrari NV
BIT
IVG
Iveco Group NV
BIT
G
Generali
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network